See more : Northwest Biotherapeutics, Inc. (NWBO) Income Statement Analysis – Financial Results
Complete financial analysis of Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shenzhen Neptunus Bioengineering Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- KCE Electronics Public Company Limited (KCEA.SG) Income Statement Analysis – Financial Results
- Corum Group Limited (COO.AX) Income Statement Analysis – Financial Results
- TLG Acquisition One Corp. (TLGAW) Income Statement Analysis – Financial Results
- AGORA Hospitality Group Co., Ltd (AGORF) Income Statement Analysis – Financial Results
- Millrock Resources Inc. (MRO.V) Income Statement Analysis – Financial Results
Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.neptunus.com
About Shenzhen Neptunus Bioengineering Co., Ltd.
Shenzhen Neptunus Bioengineering Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products primarily in China. It offers drugs in the fields of anti-tumor, cardio-cerebrovascular, marine drugs, and other fields. The company was founded in 1989 and is based in Shenzhen, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 36.42B | 37.83B | 41.05B | 40.02B | 41.49B | 38.38B | 24.94B | 13.61B | 11.12B | 9.80B | 7.99B | 6.42B | 5.31B | 4.00B | 2.71B | 2.21B | 2.50B | 2.69B | 2.66B | 2.32B | 1.28B | 829.43M | 765.05M | 198.98M | 88.39M | 64.48M | 62.67M | 77.83M | 49.82M |
Cost of Revenue | 32.87B | 34.05B | 36.66B | 35.38B | 35.97B | 33.34B | 21.34B | 11.58B | 9.49B | 8.37B | 6.78B | 5.45B | 4.42B | 3.34B | 2.24B | 1.86B | 2.14B | 2.33B | 2.41B | 1.85B | 924.26M | 231.30M | 235.01M | 41.87M | 19.96M | 16.43M | 15.54M | 19.64M | 20.60M |
Gross Profit | 3.55B | 3.79B | 4.40B | 4.65B | 5.52B | 5.04B | 3.60B | 2.02B | 1.63B | 1.43B | 1.21B | 970.06M | 880.84M | 656.99M | 466.31M | 350.15M | 351.57M | 361.60M | 247.16M | 475.80M | 357.39M | 598.13M | 530.04M | 157.11M | 68.43M | 48.05M | 47.13M | 58.19M | 29.22M |
Gross Profit Ratio | 9.76% | 10.02% | 10.71% | 11.61% | 13.31% | 13.13% | 14.42% | 14.87% | 14.65% | 14.59% | 15.14% | 15.11% | 16.60% | 16.43% | 17.21% | 15.83% | 14.09% | 13.44% | 9.30% | 20.49% | 27.89% | 72.11% | 69.28% | 78.96% | 77.42% | 74.52% | 75.20% | 74.77% | 58.65% |
Research & Development | 47.94M | 48.43M | 39.23M | 38.17M | 42.19M | 44.85M | 101.09M | 40.14M | 50.61M | 44.74M | 45.89M | 42.23M | 22.36M | 18.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 367.56M | 400.58M | 410.47M | 456.98M | 557.18M | 566.17M | 215.88M | 118.65M | 126.49M | 137.22M | 128.92M | 121.52M | 102.67M | 98.60M | 166.30M | 150.79M | 156.97M | 200.07M | 446.54M | 74.57M | 157.53M | 136.63M | 95.64M | 31.19M | 11.61M | 8.93M | 10.78M | 38.42M | 17.95M |
Selling & Marketing | 1.39B | 1.52B | 1.53B | 1.66B | 1.89B | 1.77B | 1.25B | 705.01M | 638.70M | 643.79M | 572.31M | 421.77M | 399.65M | 272.64M | 237.86M | 193.87M | 149.37M | 178.28M | 226.92M | 277.65M | 323.42M | 359.51M | 309.93M | 32.88M | 24.74M | 11.63M | 15.38M | 0.00 | 0.00 |
SG&A | 2.75B | 1.92B | 1.94B | 2.12B | 2.45B | 2.34B | 1.46B | 823.66M | 765.20M | 781.01M | 701.23M | 543.28M | 502.32M | 371.24M | 404.16M | 344.66M | 306.34M | 378.35M | 673.46M | 352.22M | 480.95M | 496.14M | 405.57M | 64.07M | 36.35M | 20.56M | 26.17M | 38.42M | 17.95M |
Other Expenses | 2.19B | 813.38M | 845.92M | 659.76M | 712.33M | 76.49M | -87.04M | 7.02M | 7.86M | 4.13M | 260.66M | 31.91M | 34.15M | 24.05M | 34.90M | 50.84M | 60.23M | 39.25M | -85.99M | 18.70M | 5.65M | 13.03M | 71.53M | 876.69K | 9.52M | 3.58M | 799.68K | 2.54K | 541.76K |
Operating Expenses | 4.99B | 2.78B | 2.83B | 2.82B | 3.21B | 3.08B | 1.99B | 1.21B | 1.14B | 1.07B | 937.98M | 739.75M | 653.71M | 490.51M | 412.93M | 349.58M | 311.10M | 382.78M | 678.38M | 358.70M | 485.35M | 500.90M | 410.82M | 64.94M | 37.10M | 21.44M | 26.96M | 38.96M | 18.23M |
Cost & Expenses | 37.89B | 36.83B | 39.48B | 38.19B | 39.18B | 36.42B | 23.34B | 12.79B | 10.63B | 9.44B | 7.72B | 6.19B | 5.08B | 3.83B | 2.66B | 2.21B | 2.45B | 2.71B | 3.09B | 2.20B | 1.41B | 732.20M | 645.83M | 106.81M | 57.06M | 37.87M | 42.50M | 58.60M | 38.83M |
Interest Income | 48.79M | 65.47M | 94.22M | 98.65M | 154.48M | 86.04M | 49.49M | 47.70M | 52.86M | 0.00 | 24.31M | 20.83M | 20.35M | 20.95M | 13.30M | 18.29M | 38.24M | 18.70M | 12.37M | 19.97M | 19.95M | 12.52M | 10.37M | 2.40M | -0.70 | -0.99 | -0.38 | -0.30 | -0.34 |
Interest Expense | 992.41M | 930.86M | 875.54M | 959.40M | 1.22B | 921.86M | 350.68M | 199.12M | 254.06M | 177.65M | 160.94M | 157.40M | 119.64M | 97.33M | 76.91M | 86.32M | 96.95M | 88.08M | 87.93M | 63.68M | 78.16M | 41.11M | 37.38M | 27.05M | 5.68M | 67.44K | 2.89M | 1.16M | 530.15K |
Depreciation & Amortization | 297.55M | 298.75M | 293.15M | 232.12M | 181.61M | 164.42M | 117.54M | 83.02M | 80.37M | 86.90M | 69.51M | 60.85M | 53.31M | 52.72M | 53.63M | 51.71M | 70.19M | 60.37M | 48.30M | 45.78M | 30.09M | 38.96M | 22.58M | 34.63M | 8.35M | 2.84M | 2.54M | 714.11K | 63.95K |
EBITDA | -141.51M | 523.20M | 1.72B | 1.42B | 2.24B | 2.11B | 1.67B | 950.22M | 994.65M | 420.12M | 587.17M | 329.83M | 275.66M | 270.80M | 50.01M | 41.36M | 118.78M | 171.19M | -600.47M | 144.99M | 135.81M | 142.86M | 163.13M | 122.66M | 39.68M | 27.73M | 20.17M | 19.23M | 10.99M |
EBITDA Ratio | -0.39% | 3.25% | 4.87% | 5.27% | 6.52% | 6.37% | 6.54% | 6.91% | 8.96% | 4.59% | 7.52% | 5.17% | 5.53% | 6.65% | 5.40% | 7.37% | 9.08% | 6.27% | -22.59% | 6.24% | -7.81% | 17.22% | 23.03% | 65.25% | 44.89% | 45.67% | 32.18% | 24.70% | 22.07% |
Operating Income | -1.47B | 952.36M | 1.73B | 1.92B | 2.55B | 1.03B | 1.25B | 647.74M | 622.74M | 153.53M | 88.75M | 78.34M | 72.95M | 83.66M | -37.82M | -25.87M | 13.24M | -14.92M | -648.46M | 23.80M | -212.20M | 49.90M | 65.88M | 67.36M | 26.29M | 27.29M | 17.63M | 18.51M | 10.93M |
Operating Income Ratio | -4.03% | 2.52% | 4.21% | 4.79% | 6.15% | 2.68% | 5.00% | 4.76% | 5.60% | 1.57% | 1.11% | 1.22% | 1.38% | 2.09% | -1.40% | -1.17% | 0.53% | -0.55% | -24.40% | 1.02% | -16.56% | 6.02% | 8.61% | 33.86% | 29.75% | 42.32% | 28.13% | 23.78% | 21.94% |
Total Other Income/Expenses | 9.56M | -1.81B | -1.15B | -1.65B | -1.68B | -804.07M | -87.04M | -143.57M | 6.49M | 3.19M | 259.59M | -118.68M | -104.35M | -48.61M | -24.15M | 48.76M | 8.13M | 33.98M | -307.74M | -88.55M | 3.90M | 12.89M | 50.39M | -6.38M | 9.52M | 5.31M | 799.69K | 2.54K | 541.76K |
Income Before Tax | -1.46B | -853.16M | 576.31M | 267.44M | 876.37M | 1.06B | 1.16B | 653.82M | 629.23M | 156.71M | 348.34M | 108.18M | 99.99M | 107.72M | -3.61M | 22.90M | 73.47M | 20.31M | -736.71M | 35.53M | -208.30M | 62.79M | 116.27M | 68.15M | 35.81M | 30.87M | 18.43M | 18.51M | 11.47M |
Income Before Tax Ratio | -4.00% | -2.25% | 1.40% | 0.67% | 2.11% | 2.75% | 4.64% | 4.81% | 5.66% | 1.60% | 4.36% | 1.69% | 1.88% | 2.69% | -0.13% | 1.04% | 2.94% | 0.75% | -27.72% | 1.53% | -16.25% | 7.57% | 15.20% | 34.25% | 40.51% | 47.88% | 29.40% | 23.79% | 23.03% |
Income Tax Expense | 260.56M | 138.97M | 318.44M | 308.73M | 361.47M | 325.21M | 332.91M | 154.97M | 110.75M | 73.09M | 119.02M | 7.10M | 38.10M | 52.44M | -4.23M | 6.06M | 27.13M | 3.30M | 1.93M | 7.88M | 10.15M | 25.33M | 3.19M | 6.00M | 4.52M | 4.49M | 94.82K | 794.12K | 36.70K |
Net Income | -1.69B | -992.13M | 257.87M | -41.29M | 514.90M | 448.21M | 639.19M | 418.40M | 474.73M | 23.79M | 117.05M | 59.07M | 52.53M | 46.67M | 14.16M | 24.30M | 38.68M | 42.47M | -741.89M | 22.07M | -219.96M | 42.23M | 79.82M | 61.53M | 31.07M | 26.15M | 18.16M | 17.01M | 11.37M |
Net Income Ratio | -4.64% | -2.62% | 0.63% | -0.10% | 1.24% | 1.17% | 2.56% | 3.08% | 4.27% | 0.24% | 1.46% | 0.92% | 0.99% | 1.17% | 0.52% | 1.10% | 1.55% | 1.58% | -27.91% | 0.95% | -17.16% | 5.09% | 10.43% | 30.92% | 35.15% | 40.56% | 28.97% | 21.85% | 22.82% |
EPS | -0.64 | -0.38 | 0.10 | -0.02 | 0.19 | 0.17 | 0.24 | 0.19 | 0.65 | 0.01 | 0.07 | 0.04 | 0.03 | 0.03 | 0.01 | -0.01 | 0.02 | 0.02 | -0.48 | 0.01 | -0.14 | 0.02 | 0.03 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
EPS Diluted | -0.64 | -0.38 | 0.10 | -0.02 | 0.19 | 0.17 | 0.24 | 0.19 | 0.65 | 0.01 | 0.07 | 0.04 | 0.03 | 0.03 | 0.01 | -0.01 | 0.02 | 0.02 | -0.48 | 0.01 | -0.14 | 0.02 | 0.03 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
Weighted Avg Shares Out | 2.63B | 2.63B | 2.63B | 2.63B | 2.65B | 2.63B | 2.65B | 2.22B | 731.71M | 1.83B | 1.78B | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B |
Weighted Avg Shares Out (Dil) | 2.63B | 2.63B | 2.63B | 2.63B | 2.65B | 2.65B | 2.65B | 2.23B | 734.08M | 1.83B | 1.78B | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B |
Source: https://incomestatements.info
Category: Stock Reports